METHOD FOR FORECASTING THE NEED FOR THE ALLOGENIC ERYTHROCY-CONTAINING COMPONENTS OF BLOOD IN THE INTRAOPERATIVE AND EARLY POSTOPERATIVE PERIODS IN CORONARY BYPASS SURGERY Russian patent published in 2018 - IPC G01N33/50 

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely, transfusiology, and concerns the prediction of the requirement for allogeneic erythrocyte-containing blood components in the intraoperative and early postoperative periods in coronary bypass surgery. To do this, identify factors that affect the need for blood transfusion and assign them appropriate prognostic indexes. With the sum of prognostic coefficients of 1–4 points, predict minimal demand and do not reserve allogeneic erythrocyte-containing blood components for this patient. With the sum of prognostic coefficients of 5–8 points, predict moderate demand and reserve one dose of allogeneic erythrocyte-containing blood components for this patient. With the sum of prognostic factors of 9 points or more predict high demand and reserve two doses of allogeneic erythrocyte-containing blood components for this patient.

EFFECT: method provides reserving of the required amount of allogeneic erythrocyte-containing blood components, taking into account the individual characteristics of cardiosurgical patients.

1 cl, 3 ex